BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11185425)

  • 1. Angiogenesis-research frontiers. A basic science conference of the New York Academy of Medicine.
    Sepp-Lorenzino L; Pan BS
    Expert Opin Investig Drugs; 2000 Apr; 9(4):929-35. PubMed ID: 11185425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics.
    Zhu Z; Bohlen P; Witte L
    Curr Cancer Drug Targets; 2002 Jun; 2(2):135-56. PubMed ID: 12188915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor.
    Zhu Z; Witte L
    Invest New Drugs; 1999; 17(3):195-212. PubMed ID: 10665474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.
    Sledge GW
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.
    Siemeister G; Martiny-Baron G; Marmé D
    Cancer Metastasis Rev; 1998 Jun; 17(2):241-8. PubMed ID: 9770121
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
    Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
    [No Abstract]   [Full Text] [Related]  

  • 11. VEGF in brain tumors.
    Machein MR; Plate KH
    J Neurooncol; 2000; 50(1-2):109-20. PubMed ID: 11245271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy.
    Sone S; Shinohara T; Nishioka Y; Yano S
    Intern Med; 2001 Feb; 40(2):167-70. PubMed ID: 11300157
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
    Ellis LM; Takahashi Y; Liu W; Shaheen RM
    Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors.
    Schlaeppi JM; Wood JM
    Cancer Metastasis Rev; 1999; 18(4):473-81. PubMed ID: 10855790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vascular endothelial growth factor in the regulation of angiogenesis.
    Ferrara N
    Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
    Arastéh K; Hannah A
    Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of tumor growth via inhibition of tumor angiogenesis.
    Plate KH
    Adv Exp Med Biol; 1998; 451():57-61. PubMed ID: 10026850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.